Patents by Inventor Dario Norberto Ramon Carrara

Dario Norberto Ramon Carrara has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ACTH IN THE TREATMENT OF AN ADRENOCORTICOTROPIC HORMONE RESPONSIVE PEDIATRIC DISORDER
    Publication number: 20240033328
    Abstract: The present invention relates to the use of ACTH having the sequence of SEQ ID NO:1 in treating an adrenocorticotropic hormone (ACTH) responsive pediatric disorder, comprising administering twice daily to an individual in need thereof 0.5-2 mg/m2 of body surface area of the ACTH. The present invention further relates to the use of ACTH having SEQ ID NO:1 in treating an adrenocorticotropic hormone (ACTH) responsive pediatric disorder, comprising administering twice daily to an individual in need thereof a treatment dose of between 0.5-2 mg/m2 of body surface area of the ACTH for at least 7 days, optionally followed by the administration of a tapered dosage for an additional 14 days.
    Type: Application
    Filed: December 17, 2021
    Publication date: February 1, 2024
    Inventors: Dario Norberto Ramon CARRARA, Laetitia Anne Christine HENRY-DELPY
  • Nestorone®/estradiol transdermal gel
    Patent number: 9682087
    Abstract: The invention discloses compositions and methods for ensuring in both women of fertile age where it ensures also a contraception with additional health benefits and in postmenopausal women where it offers a hormonal therapy with additional medical benefits such as the potential for lower risk of thrombosis. The aforementioned compositions comprising NES as a potent progestational and antiovulatory agent with no androgenic nor estrogenic nor glucocorticoid effect, and combined with estradiol formulated for non-oral transdermal administration as specific daily doses.
    Type: Grant
    Filed: December 17, 2010
    Date of Patent: June 20, 2017
    Assignees: The Population Council, Inc., Antares Pharma IPL AG
    Inventors: Regine Sitruk-Ware, Dario Norberto Ramon Carrara, Arnaud Grenier
  • NESTORONE®/ESTRADIOL TRANSDERMAL GEL
    Publication number: 20130045953
    Abstract: The invention discloses compositions and methods for ensuring in both women of fertile age where it ensures also a contraception with additional health benefits and in postmenopausal women where it offers a hormonal therapy with additional medical benefits such as the potential for lower risk of thrombosis. The aforementioned compositions comprising NES as a potent progestational and antiovulatory agent with no androgenic nor estrogenic nor glucocorticoid effect, and combined with estradiol formulated for non-oral transdermal administration as specific daily doses.
    Type: Application
    Filed: December 17, 2010
    Publication date: February 21, 2013
    Applicants: ANTARES PHARMA IPL AG, THE POPULATION COUNCIL, INC.
    Inventors: Regine Sitruk-Ware, Dario Norberto Ramon Carrara, Arnaud Grenier
  • Transdermal delivery of estradiol and process for manufacturing said device
    Patent number: 5705185
    Abstract: The present invention relates to a transdermal delivery device for estradiol where the metabolic degradation of estradiol to estrone during permeation is inhibited by another substance in the transdermal delivery device. The transdermal device also includes a compound for enhancing the rate of estradiol permeation. The transdermal delivery device containing the inhibitor and enhancer can also be used to simultaneously deliver both estradiol and a progestin at therapeutic rates.
    Type: Grant
    Filed: January 11, 1996
    Date of Patent: January 6, 1998
    Assignee: Beta Pharmaceuticals Co.
    Inventors: Francisco Jose Evaristo Stefano, Jose Adrian Nowogrodski, Dario Norberto Ramon Carrara